Neuroprotection for premature infants?: another perspective on caffeine
- PMID: 22253397
- DOI: 10.1001/jama.2011.2026
Neuroprotection for premature infants?: another perspective on caffeine
Comment on
-
Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity.JAMA. 2012 Jan 18;307(3):275-82. doi: 10.1001/jama.2011.2024. JAMA. 2012. PMID: 22253394 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
